Early Onset Intrauterine Growth Restriction in a Mouse Model of Gestational Hypercholesterolemia and Atherosclerosis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Busso, Dolores ^a   Mascareño, Lilian ^a   Salas, Francisca ^a   Berkowitz, Loni ^a   Santander, Nicolás ^a   Quiroz, Alonso ^a   Amigo, Ludwig ^a   Valdés, Gloria ^b   Rigotti, Attilio ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; LDLR PROTEIN, HUMAN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DEVELOPMENTAL STAGE; EMBRYO DEVELOPMENT; FEMALE; FETUS; FETUS DEVELOPMENT; FETUS GROWTH; FETUS WEIGHT; GESTATIONAL ATHEROSCLEROSIS; GESTATIONAL HYPERCHOLESTEROLEMIA; HYPERCHOLESTEROLEMIA; INTRAUTERINE GROWTH RETARDATION; MOUSE; NIDATION; NONHUMAN; PREGNANCY DISORDER; VITAMIN SUPPLEMENTATION; ANIMAL; BREEDING; DIET SUPPLEMENTATION; DISEASE MODEL; DRUG EFFECTS; FETAL GROWTH RETARDATION; GENETICS; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PREGNANCY;

MUS;

ANIMALS; ATHEROSCLEROSIS; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; EMBRYONIC DEVELOPMENT; FEMALE; FETAL GROWTH RETARDATION; FETUS; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MICE; MICE, KNOCKOUT; PREGNANCY; PREGNANCY, ANIMAL; RECEPTORS, LDL; VITAMIN E;

EID: 84930817000     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/280497     Document Type: Article

References (54)

1. D. J. P. Barker and P. M. Clark, "Fetal undernutrition and disease in later life, " Reviews of Reproduction, vol. 2, no. 2, pp. 105-112, 1997.
2. C. E. Aiken and S. E. Ozanne, "Sex differences in developmental programmingmodels, " Reproduction, vol. 145, no. 1, pp. R1-R13, 2013.
3. A. J. Watkins and T. P. Fleming, "Blastocyst environment and its influence on offspring cardiovascular health: the heart of the matter, " Journal of Anatomy, vol. 215, no. 1, pp. 52-59, 2009.
4. C. Napoli, F. P. DArmiento, F. P. Mancini et al., "Fatty streak formation occurs in human fetal aortas and is greatly enhanced maternal, hypercholesterolemia. Intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atheroeclerotic lesions, " Journal of Clinical Investigation, vol. 100, no. 11, pp. 2680-2690, 1997.
5. Y. Ikari, B. M. McManus, J. Kenyon, and S. M. Schwartz, "Neonatal intima formation in the human coronary artery, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 9, pp. 2036-2040, 1999.
6. A. Liguori, F. P. DArmiento, A. Palagiano et al., "Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids, " BJOG: An International Journal of Obstetrics and Gynaecology, vol. 114, no. 12, pp. 1547-1556, 2007.
7. A. Leiva, C. Diez de Medina, R. Salsoso et al., "Maternal hypercholesterolemia in pregnancy associates with umbilical vein endothelial dysfunction: role of endothelial nitric oxide synthase and arginase II, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 10, pp. 2444-2453, 2013.
8. M. R. Skilton, J. S. A. Viikari, M. Juonala et al., "Fetal growthand preterm birth influence cardiovascular risk factors and arterial health in young adults: the cardiovascular risk in young finns study, "Arteriosclerosis, Thrombosis, andVascular Biology, vol. 31, no. 12, pp. 2975-2981, 2011.
9. Z. Wang, Z. Huang, G. Lu, L. Lin, and M. Ferrari, "Hypoxia during pregnancy in rats leads to early morphological changes of atherosclerosis in adult offspring, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 296, no. 5, pp. H1321-H1328, 2009.
10. V. A. Cortes, D. Busso, P. Mardones et al., "Advances in the physiological and pathological implications of cholesterol, " Biological reviews of the Cambridge Philosophical Society, vol. 88, no. 4, pp. 825-843, 2013.
11. C. Napoli, J. L. Witztum, F. Calara, F. de Nigris, and W. Palinski, "Maternal hypercholesterolemia enhances atherogenesis in normocholesterolemic rabbits, which is inhibited by antioxidant or lipid-lowering intervention during pregnancy: an experimental model of atherogenic mechanisms in human fetuses, " Circulation Research, vol. 87, no. 10, pp. 946-952, 2000.
12. A. Montoudis, L. Simoneau, L. Brissette, J. Forest, R. Savard, and J. Lafond, "Impact of a cholesterol enriched diet on maternal and fetal plasma lipids and fetal deposition in pregnant rabbits, " Life Sciences, vol. 64, no. 26, pp. 2439-2450, 1999.
13. O. Picone, P. Laigre, L. Fortun-Lamothe et al., "Hyperlipidic hypercholesterolemic diet in prepubertal rabbits affects gene expression in the embryo, restricts fetal growth and increases offspring susceptibility to obesity, " Theriogenology, vol. 75, no. 2, pp. 287-299, 2011.
14. C. Napoli, F. de Nigris, J. S. Welch et al., "Maternal hypercholesterolemia during pregnancy promotes early atherogenesis in LDL receptor-deficient mice and alters aortic gene expression determined by microarray, " Circulation, vol. 105, no. 11, pp. 1360-1367, 2002.
15. N. Goharkhay, E. Sbrana, P. K. Gamble et al., "Characterization of a murine model of fetal programming of atherosclerosis, " American Journal of Obstetrics and Gynecology, vol. 197, no. 4, pp. 416. e1-416. e5, 2007.
16. G. S. Getz andC. A. Reardon, "Diet andmurine atherosclerosis, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 2, pp. 242-249, 2006.
17. N. Goharkhay, E. H. Tamayo, H. Yin, G. D. V. Hankins, G. R. Saade, and M. Longo, "Maternal hypercholesterolemia leads to activation of endogenous cholesterol synthesis in the offspring, " The American Journal of Obstetrics and Gynecology, vol. 199, no. 3, pp. 273. e1-273. e6, 2008.
18. K. K. S. Bhasin, A. van Nas, L. J. Martin, R. C. Davis, S. U. Devaskar, and A. J. Lusis, "Maternal low-protein diet or hypercholesterolemia reduces circulating essential amino acids and leads to intrauterine growth restriction, " Diabetes, vol. 58, no. 3, pp. 559-566, 2009.
19. T. O. Scholl, X. Chen, M. Sims, and T. P. Stein, "Vitamin E: maternal concentrations are associated with fetal growth, " The American Journal of Clinical Nutrition, vol. 84, no. 6, pp. 1442-1448, 2006.
20. M. Saker, N. Soulimane Mokhtari, S. A. Merzouk, H. Merzouk, B. Belarbi, and M. Narce, "Oxidant and antioxidant status in mothers and their newborns according to birthweight, " European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 141, no. 2, pp. 95-99, 2008.
21. W. Palinski and C. Napoli, "The fetal origins of atherosclerosis: Maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis, " FASEB Journal, vol. 16, no. 11, pp. 1348-1360, 2002.
22. K. Hartvigsen, C. J. Binder, L. F. Hansen et al., "A diet-induced hypercholesterolemic murine model to study atherogenesis without obesity and metabolic syndrome, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 878-885, 2007.
23. M. R. Dilworth, L. C. Kusinski, B. C. Baker et al., "Defining fetal growth restriction in mice: a standardized and clinically relevant approach, " Placenta, vol. 32, no. 11, pp. 914-916, 2011.
24. A. Jimenez, R. Fernandez, N. Madrid-Bury et al., "Experimental demonstration that pre-and post-conceptional mechanisms influence sex ratio in mouse embryos, " Molecular Reproduction and Development, vol. 66, no. 2, pp. 162-165, 2003.
25. C. C. Allain, L. S. Poon, C. S. G. Chan, W. Richmond, and P. C. Fu, "Enzymatic determination of total serum cholesterol, " Clinical Chemistry, vol. 20, no. 4, pp. 470-475, 1974.
26. C. L. Williams, J. L. Teeling, V. H. Perry, and T. P. Fleming, "Mouse maternal systemic inflammation at the zygote stage causes blunted cytokine responsiveness in lipopolysaccharidechallenged adult offspring, " BMC Biology, vol. 9, article 49, 2011.
27. J. J. Eckert, R. Porter, A. J. Watkins et al., "Metabolic induction and early responses of mouse blastocyst developmental programming following maternal low protein diet affecting lifelong health, " PLoS ONE, vol. 7, no. 12, Article IDe52791, 2012.
28. K. M. Luzzo, Q. Wang, S. H. Purcell et al., "High fat diet induced developmental defects in themouse: oocytemeiotic aneuploidy and fetal growth retardation/brain defects, " PLoS ONE, vol. 7, no. 11, Article ID e49217, 2012.
29. A. J. Watkins, E. S. Lucas, A. Wilkins, F. R. A. Cagampang, and T. P. Fleming, "Maternal periconceptional and gestational low protein diet affects mouse offspring growth, cardiovascular and adipose phenotype at 1 year of age, " PLoS ONE, vol. 6, no. 12, Article ID e28745, 2011.
30. W. Y. Kwong, D. J. Miller, A. P. Wilkins et al., "Maternal low protein diet restricted to the preimplantation period induces a gender-specific change on hepatic gene expression in rat fetuses, " Molecular Reproduction and Development, vol. 74, no. 1, pp. 48-56, 2007.
31. N. Igosheva, A. Y. Abramov, L. Poston et al., "Maternal dietinduced obesity alters mitochondrial activity and redox status in mouse oocytes and zygotes, " PLoS ONE, vol. 5, no. 4, Article ID e10074, 2010.
32. W. Y. Kwong, A. E. Wild, P. Roberts, A. C. Willis, and T. P. Fleming, "Maternal undernutrition during the preimplantation period of rat development causes blastocyst abnormalities and programming of postnatal hypertension, " Development, vol. 127, no. 19, pp. 4195-4202, 2000.
33. T. Forsen, J. G. Eriksson, J. Tuomilehto, C. Osmond, and D. J. P. Barker, "Growth in utero and during childhood among women who develop coronary heart disease: longitudinal study, " British Medical Journal, vol. 319, no. 7222, pp. 1403-1407, 1999.
34. J. G. Eriksson, E. Kajantie, C. Osmond, K. Thornburg, and D. J. P. Barker, "Boys live dangerously in the womb, " The American Journal of Human Biology, vol. 22, no. 3, pp. 330-335, 2010.
35. F. Lu, E. Bytautiene, E. Tamayo et al., "Gender-specific effect of overexpression of sFlt-1 in pregnant mice on fetal programming of blood pressure in the offspring later in life, " The American Journal of Obstetrics and Gynecology, vol. 197, no. 4, pp. 418. e1-418. e5, 2007.
36. J. S. Gilbert, S. P. Ford, A. L. Lang et al., "Nutrient restriction impairs nephrogenesis in a gender-specific manner in the ovine fetus, " Pediatric Research, vol. 61, no. 1, pp. 42-47, 2007.
37. D. ORegan, C. J. Kenyon, J. R. Seckl, and M. C. Holmes, "Glucocorticoid exposure in late gestation in the rat permanently programs gender-specific differences in adult cardiovascular and metabolic physiology, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 287, no. 5, pp. E863-E870, 2004.
38. L. E. Vos, A. Oren, M. L. Bots, W. H. M. Gorissen, D. E. Grobbee, andC. S. P. M. Uiterwaal, "Birth size and coronary heart disease risk score in young adulthood. The atherosclerosis risk in young adults (ARYA) study, " European Journal of Epidemiology, vol. 21, no. 1, pp. 33-38, 2006.
39. U. Pecks, M. Brieger, B. Schiessl et al., "Maternal and fetal cord blood lipids in intrauterine growth restriction, " Journal of Perinatal Medicine, vol. 40, no. 3, pp. 287-296, 2012.
40. C. Napoli, C. K. Glass, J. L. Witztum, R. Deutsch, F. P. DArmiento, and W. Palinski, "Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study, " The Lancet, vol. 354, no. 9186, pp. 1234-1241, 1999.
41. U. Pecks, W. Rath, R. Caspers et al., "Oxidatively modified LDL particles in the human placenta in early and late onset intrauterine growth restriction, " Placenta, vol. 34, no. 12, pp. 1142-1149, 2013.
42. J. L. Stanley, I. J. Andersson, C. J. Hirt et al., "Effect of the antioxidant tempol on fetal growth in amousemodel of fetal growth restriction, " Biology of Reproduction, vol. 87, no. 1, article 25, pp. 1-8, 2012.
43. S. Valastyan, V. Thakur, A. Johnson, K. Kumar, and D. Manor, "Novel transcriptional activities of vitamin E: inhibition of cholesterol biosynthesis, " Biochemistry, vol. 47, no. 2, pp. 744-752, 2008.
44. T. Watkins, P. Lenz, A. Gapor, M. Struck, A. Tomeo, and M. Bierenbaum, " γ-Tocotrienol as a hypocholesterolemic and antioxidant agent in rats fed atherogenic diets, " Lipids, vol. 28, no. 12, pp. 1113-1118, 1993.
45. R. J. Nicolosi, C. W. Lawton, and T. A. Wilson, "Vitamin E reduces plasma low density lipoprotein cholesterol, LDL oxidation, and early aortic atherosclerosis compared with black tea in hypercholesterolemic hamsters, " Nutrition Research, vol. 19, no. 8, pp. 1201-1214, 1999.
46. J. Zingg and A. Azzi, "Non-antioxidant activities of vitamin E, " Current Medicinal Chemistry, vol. 11, no. 9, pp. 1113-1133, 2004.
47. D. Wu, L. Liu, M. Meydani, and S. N. Meydani, "Vitamin E increases production of vasodilator prostanoids in human aortic endothelial cells through opposing effects on cyclooxygenase-2 and phospholipase A2, " Journal of Nutrition, vol. 135, no. 8, pp. 1847-1853, 2005.
48. K. Tran and A. C. Chan, "R, R, R-α-tocopherol potentiates prostacyclin release in human endothelial cells. Evidence for structural specificity of the tocopherol molecule, " Biochimica et Biophysica Acta-Lipids and Lipid Metabolism, vol. 1043, no. 2, pp. 189-197, 1990.
49. H. D. Sesso, J. E. Buring, W. G. Christen et al., "Vitamins E and C in the prevention of cardiovascular disease in men: the physicians health study II randomized controlled trial, " Journal of the American Medical Association, vol. 300, no. 18, pp. 2123-2133, 2008.
50. M. Shiomi, T. Koike, and T. Ishida, "Genetically modified animal models for lipoprotein research, " in Lipoproteins-Role in Health and Diseases, S. Frank and G. Kostner, Eds., chapter 22, InTech, 2012.
51. J. L. Goldstein, T. Kita, and M. S. Brown, "Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia, "TheNew England Journal of Medicine, vol. 309, no. 5, pp. 288-296, 1983.
52. S. Ishibashi, M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz, "Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery, " Journal of Clinical Investigation, vol. 92, no. 2, pp. 883-893, 1993.
53. A. H. Lichtman, S. K. Clinton, K. Iiyama, P. W. Connelly, P. Libby, andM. I. Cybulsky, "Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 8, pp. 1938-1944, 1999.
54. G. Papacleovoulou, S. Abu-Hayyeh, E. Nikolopoulou et al., "Maternal cholestasis during pregnancy programs metabolic disease in offspring, " Journal of Clinical Investigation, vol. 123, no. 7, pp. 3172-3181, 2013.